Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods

References

• Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology (6th Edition). Elsevier Mosby, Philadelphia, PA, USA (2009).
   Google Scholar
• Hovi L, Saxen H, Saarinen-Pihkala UM, Vettenranta K, Meri T, Richardson M. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Pediatr. Blood Cancer48, 28–34 (2007).
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Addison RM, McLaughlin L et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr. Infect. Dis. J.26, 558–564 (2007).
   PubMed Web of Science ®Google Scholar
• Hale KA, Shaw PJ, Dalla-Pozza L, MacIntyre CR, Isaacs D, Sorrell TC. Epidemiology of paediatric invasive fungal infections and a case–control study of risk factors in acute leukaemia or post stem cell transplant. Br. J. Haematol149, 263–272 (2010).
   PubMed Web of Science ®Google Scholar
• Castagnola E, Conte M, Parodi S, Papio F, Caviglia I, Haupt R. Incidence of bacteremias and invasive mycoses in children with high risk neuroblastoma. Pediatr. Blood Cancer49, 672–677 (2007).
   PubMedGoogle Scholar
• Castagnola E, Bagnasco F, Faraci M et al. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant41, 339–347 (2008).
   PubMed Web of Science ®Google Scholar
• Castagnola E, Rossi MR, Cesaro S et al. Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study. Pediatr. Blood Cancer55, 1103–1107 (2010).
   PubMed Web of Science ®Google Scholar
• Urrea M, Pons M, Serra M, Latorre C, Palomeque A. Prospective incidence study of nosocomial infections in a pediatric intensive care unit. Pediatr. Infect. Dis. J.22, 490–494 (2003).
   PubMedGoogle Scholar
• Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood110, 3532–3539 (2007).
   PubMed Web of Science ®Google Scholar
• Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr. Radiol.33, 453–460 (2003).
   PubMed Web of Science ®Google Scholar
• Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn. Microbiol. Infect. Dis17, 103–109 (1993).
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Bergmann OJ, Larsson L, Nielsen HV, Jarløv JO, Christensson B. Detection of candidaemia in patients with and without underlying haematological disease. Clin. Microbiol. Infect.16, 855–862 (2010).
   PubMed Web of Science ®Google Scholar
• Duthie R, Denning DW. Aspergillus fungemia: report of two cases and review. Clin. Infect. Dis.20, 598–605 (1995).
   PubMed Web of Science ®Google Scholar
• Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am. J. Clin. Pathol86, 518–523 (1986).
   PubMed Web of Science ®Google Scholar
• Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J. Microbiol.43, 65–84 (2005).
   PubMed Web of Science ®Google Scholar
• Horvath LL, George BJ, Murray CK, Harrison LS, Hospenthal DR. Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for Candida growth detection. J. Clin. Microbiol.42, 115–118 (2004).
   PubMed Web of Science ®Google Scholar
• Klont RR, Mennink-Kersten MA, Verweij PE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin. Infect. Dis.39, 1467–1474 (2004).
   PubMed Web of Science ®Google Scholar
• Maertens JA, Klont R, Masson C et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin. Infect. Dis.44, 1329–1336 (2007).
   PubMed Web of Science ®Google Scholar
• Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis42, 1417–1727 (2006).
   PubMed Web of Science ®Google Scholar
• Wheat LJ, Walsh TJ. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur. J. Clin. Microbiol. Infect. Dis.27, 245–251 (2008).
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Letscher-Bru V, Oprea C et al.Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J. Clin. Oncol20, 1898–1906 (2002).
   PubMed Web of Science ®Google Scholar
• Hayden R, Pounds S, Knapp K et al. Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatr. Infect. Dis. J27, 815–819 (2008).
   PubMed Web of Science ®Google Scholar
• Castagnola E, Furfaro E, Caviglia I et al. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation. Clin. Microbiol. Infect.16, 1197–1203 (2010).
   PubMed Web of Science ®Google Scholar
• Armenian SH, Nash KA, Kapoor N et al. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients. J. Pediatr. Hematol. Oncol31, 920–926 (2009).
   PubMed Web of Science ®Google Scholar
• Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J. Infect. Dis.190, 641–649 (2004).
   PubMed Web of Science ®Google Scholar
• Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer91, 311–318 (2001).
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MA, Ruegebrink D, Klont RR et al. Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J. Clin. Microbiol43, 3925–3931 (2005).
   PubMed Web of Science ®Google Scholar
• Sulahian A, Touratier S, Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N. Engl. J. Med349, 2366 –2367 (2003).
   PubMed Web of Science ®Google Scholar
• Orlopp K, von Lilienfeld-Toal M, Marklein G et al. False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem? J. Antimicrob. Chemother62, 1109–1112 (2008).
   PubMed Web of Science ®Google Scholar
• Aubry A, Porcher R, Bottero J et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with β-lactam antibiotics in patients with hematological disorders. J. Clin. Microbiol44, 389–394 (2006).
   PubMed Web of Science ®Google Scholar
• Mori Y, Nagasaki Y, Kamezaki K et al. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma. Am. J. Hematol85, 449–451 (2010).
   PubMed Web of Science ®Google Scholar
• Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin. Infect. Dis40, 1762–1769 (2005).
   PubMed Web of Science ®Google Scholar
• Husain S, Clancy CJ, Nguyen MH et al. Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin. Vaccine Immunol15, 1760–1763 (2008).
   PubMedGoogle Scholar
• Nguyen MH, Jaber R, Leather HL et al. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J. Clin. Microbiol45, 2787–2792 (2007).
   PubMed Web of Science ®Google Scholar
• Desai R, Ross LA, Hoffman JA. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis. Pediatr. Infect. Dis. J28, 283–286 (2009).
   PubMed Web of Science ®Google Scholar
• Das SK, Bhattacharya S, Mitra K et al. Central nervous system fungal infection – a report of three cases. J. Indian. Med. Assoc102, 634–636 (2004).
   PubMedGoogle Scholar
• Roilides E, Pavlidou E, Papadopoulos F et al. Cerebral aspergillosis in an infant with corticosteroid-resistant nephrotic syndrome. Pediatr. Nephrol18, 450–453 (2003).
   PubMed Web of Science ®Google Scholar
• Viscoli C, Machetti M, Gazzola P et al.Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J. Clin. Microbiol40, 1496–1499 (2002).
   PubMed Web of Science ®Google Scholar
• Kedzierska A, Kochan P, Pietrzyk A, Kedzierska J. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1→3)-β-D-glucan antigens. Eur. J. Clin. Microbiol. Infect. Dis.26, 755–766 (2007).
   PubMed Web of Science ®Google Scholar
• Alexander BD, Pfaller MA. Contemporary tools for the diagnosis and management of invasive mycoses. Clin. Infect. Dis43, 15–27 (2006).
   Web of Science ®Google Scholar
• Odabasi Z, Mattiuzzi G, Estey E et al. β-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis39, 199–205 (2004).
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Kohno S, Mitsutake K et al. Plasma (1→3)-β-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J. Clin. Microbiol.33, 3115–3118 (1995).
   PubMed Web of Science ®Google Scholar
• Senn L, Robinson JO, Schmidt S et al. 1,3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin. Infect. Dis46, 878–885 (2008).
   PubMed Web of Science ®Google Scholar
• Presterl E, Parschalk B, Bauer E, Lassnigg A, Hajdu S, Graninger W. Invasive fungal infections and (1,3)-β-D-glucan serum concentrations in long-term intensive care patients. Int. J. Infect. Dis13, 707–712 (2009).
   PubMed Web of Science ®Google Scholar
• Racil Z, Kocmanova I, Lengerova M et al. Difficulties in using 1,3-{β}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies – high frequency of false-positive results and their analysis. J. Med. Microbiol59, 1016–1022 (2010).
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Alexander BD, Kett DH et al. Multicenter clinical evaluation of the (1,3)- β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis41, 654–659 (2005).
   PubMed Web of Science ®Google Scholar
• Smith PB, Benjamin DK Jr, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ. Quantification of 1,3-β-D-glucan levels in children: preliminary data for diagnostic use of the β-glucan assay in a pediatric setting. Clin. Vaccine Immunol14, 924–925 (2007).
   PubMed Web of Science ®Google Scholar
• Mokaddas E, Burhamah MH, Khan ZU, Ahmad S. Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species. BMC Infect. Dis10, 292 (2010).
   PubMed Web of Science ®Google Scholar
• Mularoni A, Furfaro E, Faraci M et al. High levels of β-D-glucan in immunocompromised children with proven invasive fungal disease. Clin. Vaccine Immunol17, 882–883 (2010).
   PubMed Web of Science ®Google Scholar
• Zhao L, Tang JY, Wang Y et al. Value of plasma β-glucan in early diagnosis of invasive fungal infection in children. Zhongguo Dang Dai Er Ke Za Zhi11, 905–908 (2009).
   PubMedGoogle Scholar
• Ellis M, Al-Ramadi B, Finkelman M et al. Assessment of the clinical utility of serial β-D-glucan concentrations in patients with persistent neutropenic fever. J. Med. Microbiol.57, 287–295 (2008).
   PubMed Web of Science ®Google Scholar
• Pazos C, Ponton J, Del Palacio A. Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J. Clin. Microb.43, 299–305 (2005).
   PubMed Web of Science ®Google Scholar
• Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1→3)-β-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol43, 5957–5962 (2005).
   PubMed Web of Science ®Google Scholar
• Desmet S, Van Wijngaerden E, Maertens J et al. Serum (1→3)-β-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J. Clin. Microb.47, 3871–3874 (2009).
   PubMed Web of Science ®Google Scholar
• Watanabe T, Yasuoka, A, Tanuma J et al. Serum (1→3) β-D-glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin. Infect. Dis.49, 1128–1131 (2009).
   PubMed Web of Science ®Google Scholar
• Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR. Reactivity of (1→3)-β-D-glucan assay with commonly used intravenous antimicrobials. Antimicrob. Agents Chemother50, 3450–3453 (2006).
   PubMed Web of Science ®Google Scholar
• Usami M, Ohata A, Horiuchi T, Nagasawa K, Wakabayashi T, Tanaka S. Positive (1→3)-β-D-glucan in blood components and release of (1→3)-β-D-glucan from depth-type membrane filters for blood processing. Transfusion42, 1189–1195 (2002).
   PubMed Web of Science ®Google Scholar
• Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic performance of the (1→3)-β-D-glucan assay for invasive fungal disease. Clin. Infect. Dis.49, 1650–1659 (2009).
   PubMed Web of Science ®Google Scholar
• Petraitiene R, Petraitis V, Hope WW et al. Cerebrospinal fluid and plasma (1→3)-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis. Antimicrob. Agents Chemother52, 4121–4129 (2008).
   PubMed Web of Science ®Google Scholar
• Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J. Clin. Microbiol37, 1510–1517 (1999).
   PubMed Web of Science ®Google Scholar
• Sendid B, Poirot JL, Tabouret M et al. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J. Med. Microbiol51, 433–442 (2002).
   PubMed Web of Science ®Google Scholar
• Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-β-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect. Dis7, 103–112 (2007).
   PubMed Web of Science ®Google Scholar
• Verduyn Lunel FM, Donnelly JP, van der Lee HA, Blijlevens NM, Verweij PE. Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy. Clin. Microbiol. Infect15, 380–386 (2009).
   PubMed Web of Science ®Google Scholar
• Rimek D, Redetzke K, Singh J, Heinrich K, Kappe R. Performance of the Candida mannan antigen detection in patients with fungemia. Mycoses47, 23–26 (2004).
   PubMed Web of Science ®Google Scholar
• Oliveri S, Trovato L, Betta P, Romeo MG, Nicoletti G. Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin. Microbiol. Infect14, 391–393 (2008).
   PubMed Web of Science ®Google Scholar
• Verduyn Lunel FM, Voss A, Kuijper EJ et al. Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis. J. Clin. Microbiol.42, 867–870 (2004).
   PubMed Web of Science ®Google Scholar
• Kurita H, Kamata T, Zhao C, Narikawa JN, Koike T, Kurashina K. Usefulness of a commercial enzyme-linked immunosorbent assay kit for Candida mannan antigen for detecting Candida in oral rinse solutions. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.107, 531–534 (2009).
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C, Gunsilius E, Gastl G et al. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J. Clin. Microbiol42, 4154–4157 (2004).
   PubMed Web of Science ®Google Scholar
• Tuon FF. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev. Iberoam. Micol24, 89–94 (2007).
   PubMedGoogle Scholar
• Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis9, 89–96 (2009).
   PubMed Web of Science ®Google Scholar
• Khlif M, Mary C, Sellami H et al. Evaluation of nested and realtime PCR assays in the diagnosis of candidaemia. Clin. Microbiol. Infect15, 656–661 (2009).
   PubMedGoogle Scholar
• von Lilienfeld-Toal M, Lehmann LE, Raadts AD et al. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J. Clin. Microbiol47, 2405–2410 (2009).
   PubMed Web of Science ®Google Scholar
• Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J. Clin. Microbiol.42, 5517–5522 (2004).
   PubMed Web of Science ®Google Scholar
• White PL, Barton R, Guiver M et al. Aconsensus on fungal polymerase chain reaction diagnosis?: a United Kingdom–Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J. Mol. Diagn8, 376–384 (2006).
   PubMed Web of Science ®Google Scholar
• Khan ZU, Ahmad S, Theyyathel AM. Detection of Aspergillus fumigatus-specific DNA, (1–3)-β-D-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats. Mycoses51, 129–135 (2008).
   PubMedGoogle Scholar
• El-Mahallawy HA, Shaker HH, Ali Helmy H, Mostafa T, Razak Abo-Sedah A. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients. Med. Mycol44, 733–739 (2006).
   PubMed Web of Science ®Google Scholar
• Scotter JM, Campbell P, Anderson TP, Murdoch DR, Chambers ST, Patton WN. Comparison of PCR–ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology37, 246–253 (2005).
   PubMed Web of Science ®Google Scholar
• Jordanides NE, Allan EK, McLintock LA et al. A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients. Bone Marrow Transplant35, 389–395 (2005).
   PubMed Web of Science ®Google Scholar
• White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin. Infect. Dis42, 479–486 (2006).
   PubMed Web of Science ®Google Scholar
• Cesaro S, Stenghele C, Calore E et al. Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases. Mycoses51, 497–504 (2008).
   PubMed Web of Science ®Google Scholar
• Badiee P, Kordbacheh P, Alborzi A, Ramzi M, Shakiba E. Molecular detection of invasive aspergillosis in hematologic malignancies. Infection36, 580–584 (2008).
   PubMed Web of Science ®Google Scholar
• Badiee P, Alborzi A, Shakiba E, Ziyaeyan M, Pourabbas B. Molecular diagnosis of Aspergillus endocarditis after cardiac surgery. J. Med. Microbiol58, 192–195 (2009).
   PubMed Web of Science ®Google Scholar
• Hummel M, Spiess B, Roder J et al. Detection of Aspergillus DNA by a nested PCR assay is able to improve the diagnosis of invasive aspergillosis in paediatric patients. J. Med. Microbiol58, 1291–1297 (2009).
   PubMed Web of Science ®Google Scholar